This paper shows that the functional human orthologue of Greatwall protein kinase (Gwl) is the "Microtubule Associated Serine/Threonine kinase-Like" protein, MAST-L. This kinase promotes mitotic entry and maintenance in human cells by inhibiting PP2A, a phosphatase that dephosphorylates cyclin B-Cdc2 substrates. The complete depletion of Gwl by siRNA arrests human cells in G2. When the levels of this kinase are only partially depleted, however, cells enter into mitosis with multiple defects and fail to inactivate the spindle assembly checkpoint (SAC). The ability of cells to remain arrested in mitosis by the SAC appears to be directly proportional to the amount of Gwl remaining. Thus, when Gwl is only slightly reduced, cells arrest at prometaphase.
INTRODUCTION
In eukaryotic cells, the mitotic state is maintained by the mitotic kinase cyclin B-Cdc2.
Historically, mitotic entry and exit was thought to be the direct consequence of cyclin B-Cdc2 activation and inactivation respectively (1) . Recent results have expanded this model to include phosphatases (2) . Specifically, recent evidence indicates that PP2A is responsible for 3 dephosphorylation of cyclin B-Cdc2 substrates and that the regulation of this dephosphorylation is required in mitotic entry and exit (3) . This suggests a new model in which the balance between cyclin B-Cdc2 and PP2A controls mitotic entry and exit. Thus, during G2 PP2A activity is high and cyclin B-Cdc2 activity low, thereby preventing phosphorylation of mitotic substrates, whereas, at mitotic entry the balance flips allowing entry into mitosis. The mechanisms controlling cyclin B-Cdc2 activity have been largely described (4) . Briefly, cyclin B-Cdc2 is inhibited during G2 by the inhibitory phosphorylation of Cdc2 on threonine 14 and tyrosine 15 by Wee1 and Myt1 kinases. Upon mitotic entry these are removed by the Cdc25 phosphatase (4) .
Finally, at mitotic exit cyclin B-Cdc2 is inhibited by the ubiquitin-dependent degradation of its regulatory subunit cyclin B (5) . Unlike cyclin B-Cdc2 regulation, very little is known about the mechanisms controlling PP2A activity during mitosis, and therefore our understanding of G2 and mitosis is incomplete.
Recently, Greatwall (Gwl) a new critical mitotic regulator has been discovered in Drosophila (6, 7). It is a member of the AGC family of serine/threonine kinases that phosphorylates substrates on S/T residues encircled by basic amino acids. (7) . Work done in Xenopus egg extracts suggested that Gwl promoted mitotic entry by controlling the auto-amplification loop of cyclin B/Cdc2 (8, 9) . However it has been recently demonstrated that the main role of this kinase is not the regulation of cyclin B-Cdc2 activity but the inhibition of PP2A, the phosphatase that dephosphorylates cyclin B-Cdc2 substrates (10, 11) .
Despite the critical roles of Gwl in mitosis, the functional human orthologue of this kinase is currently unknown. The human protein with the closest homology to Drosophila and Xenopus Gwl is the Microtubule Associated Serine/Threonine kinase Like (MAST-L) (50,2% and 65.7% of sequence homology respectively) ( Figure S1 ). In addition to the high homology of MAST-L with the other members of the Gwl family, it also contains a very long T-loop (>500 amino acids) that separates the kinase subdomains VII and VIII, a particular feature exclusive to Gwl kinases. In 4 contrast, although MAST-L was first classified as a member of the MAST family, it contains very little homology to any of the MAST kinases. All the members of the MAST family are large enzymes (1309-2444 amino acids) with a short T-loop (31 amino acids for MAST1), and contain a PDZ domain in the C terminus. However, MAST-L has minimal homology to MAST proteins (10,4% with MAST1), and no PDZ domain, suggesting that it is not a true member of the MAST family.
Very little is known about the role of MAST-L in human cells, with only two publications to date.
Both of these publications focus on the role of MAST-L in Autosomal Dominant
Thrombocytopenia showing that a single point mutation (E167D) in the N-terminal kinase domain correlates with this syndrome (12) , while transient knockdown in zebrafish results in a reduction of circulating thrombocytes (13) .
In the present study, we verified that MAST-L is the functional human orthologue of Gwl. Using siRNA knockdown of hGwl we show in human cells that this kinase mediates mitotic entry and maintains the mitotic state by inhibiting PP2A and thus, keeping the correct equilibrium between cyclin B-Cdc2 and PP2A.
RESULTS

MAST-L is the functional human homologue of Xenopus Greatwall
To analyse the role of Greatwall in human cells, we cloned the closest related human protein to the Drosophila and Xenopus Greatwall, the Microtubule Associated Serine/Threonine KinaseLike protein (MAST-L) (12) . Our previous results demonstrated that the depletion of Greatwall from mitotic egg extracts induced the loss of the mitotic state. To check whether MAST-L corresponds to the Greatwall orthologue, we translated MAST-L in "M-phase frog egg extracts"
(CSF extracts) and tested its capacity to rescue the loss of endogenous Greatwall. The expression, at endogenous levels, of wild type MAST-L in these CSF extracts completely rescued the mitotic state (Fig. S2A) . However, expression of a kinase-dead mutant of MAST-L failed to rescue, indicating that MAST-L is the functional ortologue of Greatwall. Thus, from now, it will be referred to as human Greatwall (hGwl) in this manuscript.
We next analysed by western blot the expression of the endogenous human protein in Hela cells.
Our antibodies clearly recognised and specifically immunoprecipitated a band around 110 KDa, the expected molecular weight of hGwl (Fig. S2B) . The levels of hGwl appeared to be constant throughout the cell cycle (Fig. 1A and Fig. S2C and D) . However a lower electrophoretic mobility of this protein appeared as cells entered mitosis, was maximal in prometaphase and disappeared by anaphase (Fig. 1A ). This lower mobility was induced by phosphorylation as λ-Phosphatase treatment reversed the shift (Fig. S2E ).
Previously in Drosophila, Gwl was identified as a nuclear protein (7). However, while hGwl is mostly present in the nucleus of interphase human cells, we also noted a consistent partial localization in the cytoplasm and at the centrosomes during G1, S and G2 phases (Fig. 1B) . The centrosomal hGwl appeared to surround γ-tubulin, indicating that hGW is localized around the pericentriolar material (Fig. 1C) . As cells entered mitosis, hGwl concentrated at the poles of the spindle and emanated out along the microtubule spindle fibres (Fig. 1B and C) . At anaphase the protein started to leave the mitotic spindle and becomes more diffuse in the cytoplasm. Finally, from telophase to cytokinesis, once the nuclear membrane reformed, most of the hGwl is localised in the nucleus, but a small fraction stayed at the cleavage furrow where it remained on the midzone microtubules although occasionally it was also observed at the mid-body (Fig. 1C) . We detected a similar localization of this protein in in U2OS cells and by using two different antibodies, one against the full-length protein and the other against the last 12 C-terminal amino acids of hGwl.
hGwl knockdown promotes G2 arrest and mitotic defects in Hela cells that can be rescued by the knockdown or the inhibition of PP2A by OA 6 It has been previously shown that depletion of Gwl in Xenopus egg extracts both prevents mitotic entry and promotes mitotic exit (8, 10, 11) .
To investigate the role of hGwl in human cells we induced its knockdown by siRNA in Hela cells.
The levels of hGwl decreased in a dose-dependent manner when increasing doses of the hGW siRNA were used, with an almost complete knockdown of this protein after 48h with 100 nM dose of this siRNA, both by western blot (Fig.1D) and immunofluorescence (Fig. 1E) .
We next analysed if knockdown of hGwl in cells resulted in any alteration in mitotic entry or in the maintenance of the mitotic state. Flow Cytometry analysis (FACS) after a 48 h siRNA treatment of asynchronous cells produced an accumulation (40%) of cells with a 4n DNA content and a notable increase of sub-diploid cells, indicating that the knockdown of hGwl induced G2/M cell cycle dependent defects and an increase in cell death (Fig. 1F ).
Immunofluorescence analysis revealed that the accumulation of cells with 4n DNA content was not primarily due to an increase in the mitotic index (6,9% of mitotic cells from 40% of knockdown cells containing 4n DNA content), but due most likely to an increase in multinuclear cells ( Fig. S3A and Fig.1G, vii) , although some of these 4n cells could be arrested in G2.
The multinuclear cells are likely the result of an improper cytokinesis, as there were numerous signs of incorrect mitotic divisions with many cells displaying DNA bridges connecting daughter cells ( Fig. S3A and Fig. 1G, vi) . Finally, in some cases we noticed a more severe cytokinesis phenotype with one daughter cell containing the complete DNA content whereas the other was completely devoid of chromatin (Fig. 1G, viii) .
In addition to multinuclear cells, we also observed significant chromosome abnormalities in mitotic cells. Metaphase cells showed either a mass of undercondensed chromatin that was scattered along the spindle (Fig. 1G, iii) or condensed chromosomes that did not correctly congress to the metaphase plate (Fig. 1G, v) . A very low number of anaphases were observed, but those that were present showed multiple lagging chromosomes and chromosome bridges (Fig. 1G,   7 iv). No major defects were observed in the spindle although some were longer and appeared to have a lower number of microtubules (Fig. 1G, iii) . These phenotypes were specific to Gwl knockdown as similar phenotypes were observed with two other siRNAs targeting different regions of hGwl mRNA ( Fig. S3B and C) .
The mitotic defects observed after hGwl knockdown are indicative of a premature exit from mitosis. To assess whether this was the case, time-lapse videos were performed on synchronised HeLa cells stably expressing EB3-GFP and H2B-CherryFP. Scramble siRNA treated cells progressed through mitosis normally ( Fig. 2A, video S1 ). One of the major phenotypes observed at a 50 nM-dose of hGwl siRNA was a decrease in the total number of cells that were able to perform mitosis during the experiment (65% versus 80% in controls), suggesting that some cells were arrested at G2, similar to what has been described in Xenopus egg extracts (11) . However, most cells were still able to enter into mitosis, albeit with numerous mitotic defects. Although the mitotic spindle structure did not contain any observable defects, in some cases the spindle rotated dynamically within the cell performing several rotations ( Fig Thus, similar to Xenopus extracts, one of the major phenotypes of hGwl knockdown is a premature exit from mitosis. The knockdown of hGwl at a 50 nM-dose induced a variety of phenotypes probably due to the intrinsic heterogeneity of the siRNA transfection procedure. To try to separate the various phenotypes we repeated the experiment using various concentrations of hGwl siRNA (25, 50 and 100 nM). As the concentration of siRNA increased, there was a shift from cells that maintained the mitotic state (cells displaying the phenotypes "Segregation Defects", "Metaphase Arrest" and the "Metaphase Delay") towards cells incapable of maintaining mitosis (cells displaying the "No Metaphase Plate" phenotype) (Fig. 3A) . Accordingly mitotic length decreased concomitantly with the increasing siRNA concentration (Fig. 3B) .
Furthermore, as the dose of siRNA increased, there was a significant delay in the time of mitotic entry (Fig 3C) , suggesting that cells were arrested in G2. To assess this issue in more detail, synchronized cells were analyzed by 2 dimensional FACS (Fig. 3D) . Both scramble and hGwl siRNA treated cells transited S and entered G2 phase with similar kinetics, indicating that hGwl is not critical for S phase progression. Entry into mitosis in scramble cells began at 8 h peaking at 9 h post-thymidine release. In contrast, there was a clear impairment in the ability of hGwl depleted cells to enter mitosis, with almost 3 times more (7.8% vs 20.9%) mitotic cells present in the scramble treated mitotic captured (nocodazole) 10 h time-point. Thus, at the highest dose of hGwl siRNA, cells arrest in G2.
It has been recently shown that the inhibition of the PP2A phosphastase activity is required to allow the phosphorylation of cyclin B-Cdc2 substrates, which promotes entry and maintains mitosis (3, 10, 11) . Therefore, we next analysed the capacity of these cells to phosphorylate the different cyclin B-Cdc2 substrates at the different doses of siRNA (Fig. 3E) . As most cells treated with a dose of 25 nM of siRNA arrest in mitosis after nocodazole treatment, we only observed a slight decrease in the levels of phosphorylation of cyclin B-Cdc2 substrates. However, at the higher doses of 50 and 100 nM, the phosphorylation levels of cyclin B-Cdc2 substrates were significantly reduced. This is most likely a result of the G2 arrest, although a partial degradation of cyclin B was also observed, probably as a result of cells that entered and subsequently slipped out of mitosis. In agreement with these results, we observed only a slight decrease in the immunostaining of cyclin B-Cdc2 substrates in mitotic hGwl-depleted cells (Fig. 3F) , whereas a significant decrease in this signal was observed when cells prematurely exited mitosis (note decondensed DNA in the presence of a mitotic spindle). This decrease in the phosphorylation pattern of cyclin B-Cdc2 substrates was specific to hGwl knockdown as it was mostly rescued by the concomitant transfection of a siRNA-resistant plasmid encoding Xenopus Gwl (Fig. S6 ).
To assess if the decrease in cyclin B-Cdc2 substrate phosphorylation after hGW knockdown could be the consequence of an increase in PP2A activity due to a loss of hGW, we performed a double hGwl-PP2A siRNA knockdown (Fig. 3G) . As expected, hGwl knockdown decreased the cyclin B-Cdc2 substrate phosphorylation by 80% in nocodazole captured cells. When PP2A siRNA knockdown was performed, we noticed that the general substrate phosphorylation pattern was partially decreased compared to the scramble siRNA. This decrease is probably due to the 15% increase in cell death induced by PP2A depletion. Importantly, the double hGwl/PP2A knockdown rescued the general phosphorylation pattern of cyclin B-Cdc2 substrates from 20% to 64%. These results indicate that the hGwl knockdown phenotype is likely mediated by increased PP2A activity. However, it is possible that the knockdown of PP2A could promote a pleiotropic effect in other phases of the cell cycle (14) . Thus, to more specifically investigate the role of Gwl in the regulation of PP2A activity at mitotic entry, we analysed if the inhibition of this phosphatase by OA could rescue the G2 arrest, the most severe phenotype observed in hGwl knockdown cells. Cells transfected with 100 nM of hGwl siRNA, were synchronised in G1/S phase, treated with OA and followed by time-lapse microscopy. The addition of OA at the end of 
DISCUSSION
Historically, mitotic entry and exit was thought to be directly equivalent to cyclin B-Cdc2 activation and inactivation respectively, while the activity of the phosphatases required for cyclin B/Cdc2 substrate dephosphorylation during mitosis was thought to be constant. According to this hypothesis the large increase in cyclin B/cdc2 activity was sufficient to over-come the background dephosphorylation of mitotic substrates, thereby promoting mitotic entry. Similarly, inactivation of the cyclin B-Cdc2 complex by cyclin B degradation was sufficient to trigger mitotic exit.
However, recent data from our and other laboratories has demonstrated that PP2A is highly regulated during mitotic entry and exit (3, 10, 11) . Therefore the old cell cycle model now must be update to include a new regulator of mitosis that modulates PP2A during this phase of the cell cycle. In this work we demonstrate that Gwl is this critical and evolutionally conserved new regulator of PP2A in human cells.
Greatwall is a novel kinase whose role is essential in Xenopus egg extracts to promote mitotic entry and to maintain the mitotic state (8, 10, 11 Depending on the level of cyclin B-Cdc2-substrate phosphorylation, cells will display different mitotic defects such as improper chromosome congression or spindle rotation, which in some cases leads to a permanent prometaphase arrest by the SAC while in others mitotic slippage. In this regard, other reports described the presence of similar mitotic defects due to a partial inhibition of cyclin-Cdk activity (15-17). For example, siRNA knockdown of cyclin A results in improper chromosome congression and spindle rotation (15). Moreover, the inhibition of cyclin B-Cdc2 activity in mitotic cells also induced mitotic slippage resulting in severe cytokinesis defects (17) (18) (19) .
The exact mechanism of how Gwl regulates PP2A activity is currently unknown, although we previously demonstrated that xGwl can bind with PP2A/A and /C (11). PP2A itself is a complicated ternary complex comprising of a catalytic subunit (C), a scaffold subunit (subunit A) and a regulatory B subunit (14) . The substrate specificity of the PP2A complex is thought to be conferred by the B subunit that include the B55 (B), B56 (B') and B72/130 (B''), with each also containing multiple isoforms. Recently PP2A-B55! was identified as a key phosphatase responsible for removing cyclin B/cdc2 phosphorylations (3). There are several possible phosphorylation sites in B55!, suggesting that this complex could be regulated by phosphorylation, perhaps by Gwl itself.
It is clear from our work and others that the classical cyclin/cdk cell cycle model, must be perfectly co-ordinated with the phosphatases (especially PP2A) for correct mitotic entry, progression and exit. In this regard, it has been shown that cyclin B-Cdc2 is capable of phosphorylating and activating Gwl kinase in vitro (8) suggesting that cyclin B-Cdc2 itself would induce PP2A inhibition through Gwl activation (Fig. 4) . Thus, it is possible that at mitotic entry, cyclin B-Cdc2 is first activated and this activation would further induce Gwl phosphorylation and activation. Accordingly, our data identified a pool of Gwl localized at the centrosome during G2 phase, the same subcellular and temporal localization where cyclin B-Cdc2 is first activated (20). 
MATERIALS AND METHODS
Chemicals, Reagents and Antibodies
MG132 and Okadaic Acid were purchase from Calbiochem (La Jolla, CA). Anti-Cyclin B1 and Cdc2 (Santa Cruz, Santa Cruz, CA), anti-Phospho-(Ser) CDK Substrate and PhosphoCdc2-Tyr15 (Cell signalling, Denver, MA), monoclonal 1D6 against PP2AC (Millipore Temecula, CA), anti-Aurora B and BUBR1 (Becton Dickinson Franklin Lakes, NJ), and monoclonal anti-Gamma and ß-Tubulin (Sigma-Aldrich) were used. Anti-Cdc25 and Cdc27 were obtained as previously described (7, (19) (20) (21) (22) . pCMVsport6-MAST-L was obtained from RZPD Deutsches Ressourcenzentrum für Genomforschung GmbH, amplified by PCR and subcloned in the pGEX4T2 plasmid. The fusion protein was expressed in Escherichia coli.
Inclusion bodies were prepared and used to immunize rabbits. Immune serum against the fulllength protein (anti-hGwl) was affinity purified on an immobilized GST-MAST-L column.
Anti-C-terminal hGwl antibodies were also generated against the last 12 aminoacids of the Cterminal sequence of this protein. Peptides were coupled to thyroglobulin for immunization and to immobilized bovine serum albumin for affinity purification as previously described (23).
Cell synchrony
Thymidine block/release synchronizations were performed as previously described (24). For Nocodazole synchrony, cells were first released from G1/S Thymidine block, and treated with 100 ng/ml of Nocodazole for 16 h. Floating cells were then removed, washed 3 times and seeded back in fresh media.
siRNA Design and Transfection
The Promega (Madison, WI) T7 Ribomax Express RNAi system was used to produce in vitro transcribed siRNAs against human Greatwall and PP2Ac. The following target sequences were identified and appropriate sense and anti-sense oligonucleotides were synthesized. For 
Immunofluorescent Staining
Cells were grown on poly-lysine coated glass coverslips and pre-permeabilised for 30 seconds in PHEM buffer (60 mM PIPES, 25 mM HEPES, 1 mM EGTA, 2 mM MgCl2) + 0.25% Triton X-100. Then cells were fixed for 10 min in PHEM buffer with 3.7% formaldehyde and 0.5% Triton X-100, washed and blocked (3% BSA, 0,1% tween 20 in PBS) for 30 min. Primary antibodies were incubated for 2 h at RT in blocking solution. Images were captured using a Leica DM6000 microscope coupled with a Coolsnap HQ2 camera, using a Leica 63X APO 1.4 lens, powered by metamorph 7.1 software. For mitotic cells 0.3 m Z-sections were taken, and deconvoluted using Huygens 3.0 software. Maximum projections and total fluorescence measurements were performed with Image J, metaphase plate measurements and false coloring were performed using Photoshop CS4 Extended software.
Live cell imaging
Thymidine synchronized cells were filmed with a Micromax YHS 1300 camera coupled to a Zeiss Axiovert 200M inverted microscope fitted with a Zeiss slider PlasDIC 32X LD A plan NA 0.4 lens, Zeiss mercury lamp, and controlled by Metamorph 7.1 software (Molecular Devices, Sunnyvale, CA, USA). Images, both phase-contrast and GFP/CherryFP fluorescence, were taken every 10-15 min. The resulting images were processed, analyzed and false colored using Photoshop CS4 Extended software. Box Graphs and statistical analysis was performed using GraphPad Prism 5 (La Jolla, CA). Mitotic entry, length, exit, and cell death were determined as described in Figure S7 . Briefly, the following parameters were used to identify mitotic entry: first appearance of a mitotic spindle with condensed chromosomes, loss of a nucleolus and rounding up of the cell from the culture plate. Exit was scored based on the first appearance of anaphase, thus visualization of chromosome separation, pinching of the membrane and appearance of a mid-body. Once activated, PP2A will promote the irreversible dephosphorylation of mitotic substrates and cell will exit mitosis until next G2 phase in when cyclin B is synthesised again. Black arrows denote pathways active during mitotic entry. Dotted arrow denotes pathways that are inhibited at mitotic entry, during mitosis or at mitotic exit.
ACKNOWLEDGMENTS
